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Autopsy findings were reviewed in 22 patients treated for uterine sarcoma at the University 
of Michigan Hospitals. Included are 11 mixed mesodermal tumors, 6 endometrial stromal 
sarcomas, and 5 leiomyosarcomas. Only one patient died with disease limited to the pelvis, 
Forty-five percent of the patients died with disease limited to the pelvis and abdomen. 
The most common site of disease above the diaphragm was the lung. Lymph nodes were 
involved in 59% of our patients. There were no obvious differences in the patterns of 
spread between the tumor types. 0 1984 Academic PXSS. hc. 
INTRODUCTION 
Uterine sarcomas represent a rare, but interesting group of tumors that are 
among the most malignant of gynecological cancers. The biologic behavior of 
these tumors remains poorly understood and attempts to elucidate their clinical 
and pathological features have been frustrated by the multiple and often complex 
classification schemes utilized. Surgical therapy will salvage some patients with 
limited disease, but the survival rates in patients with extrauterine disease are 
uniformly poor and there has been no significant advance in adjuvant therapy. 
In an effort to improve results it will be necessary to alter treatment protocols 
by taking into account the biological behavior of these tumors. This report 
examines the autopsy findings of a group of patients treated for uterine sarcomas 
by evaluating their pattern of spread and searching for differences between the 
tumor types which might alter the approach to therapy. 
MATERIALS AND METHODS 
A review was made of all patients treated for uterine sarcoma at the University 
of Michigan Hospitals between January 1, 1936 and June 30, 1983. Those patients 
having a postmortem examination were identified and are the subject of this 
report. The autopsy protocols were studied and the original histology slides 
reviewed by a gynecologic pathologist. The protocols and slides were obtained 
’ To whom correspondence should be addressed at Three Crosses Ob-Gyn, 299 E. Montana, Las 
Cruces. New Mexico 88005. 
168 
00!90-8258184 $1.50 
Copyright Q 1984 by Academic Press, Inc. 
AU rights of reproduction in any form reserved. 
UTERINE SARCOMA AUTOPSY FINDINGS 169 
in five cases where the examination was performed elsewhere and similarly 
reviewed. Additional slides were cut when the originals were of poor quality. 
Tumors were classified using the criteria of Ober [I]. Those neoplasms containing 
only endometrial stromal cells were diagnosed as endometrial stromal sarcomas 
only if they had infiltrating borders and if the mitotic activity was greater than 
10 mitoses/lO HPFs [2]. Patients with endolymphatic stromal myosis, a tumor 
with low malignant potential, were excluded from this study. Leiomyosarcomas 
were diagnosed in smooth muscle tumors with more than 5 mitoses/lO HPFs 
with 3 + cellular atypia or more than 10 mitoses/lO HPFs with any degree of 
atypia [3]. Mixed mesodermal tumors were divided into homologous and het- 
erologous groups. 
RESULTS 
For the period January 1, 1936 to June 30, 1983, 203 patients were evaluated 
at the University of Michigan Hospitals with a diagnosis of uterine sarcoma. 
Twenty-two of these patients had a postmortem examination. The group included 
5 patients with leiomyosarcoma, 6 patients with endometrial stromal sarcoma, 
and 11 with mixed mesodermal sarcoma. Three of the autopsies have been 
previously reported [4]. 
Two patients with mixed mesodermal tumors had received prior pelvic radiation 
therapy, one for adenocarcinoma of the endometrium 8 years prior to her pre- 
sentation and one for squamous carcinoma of the cervix 20 years prior to her 
presentation with sarcoma. Four patients were treated by surgery only, four 
patients were treated by surgery and chemotherapy, three patients by surgery 
and radiation therapy, and two patients by all three modalities. Two patients 
were treated by radiation alone and two patients solely by chemotherapy. Five 
patients with far advanced disease received only supportive therapy. 
The specific site and frequency of metastases at autopsy are shown in Table 
1. All 22 patients had disease in the pelvis, but only one patient had disease 
confined to the pelvis. The remaining 21 patients died with diffuse upper abdominal 
disease. Extraabdominal disease was found in 12 patients, with the lung being 
the organ most frequently involved. Of the 12 patients having brain examinations, 
2 showed metastatic brain lesions. Nodal disease occurred in 59% of our patients. 
Based on the autopsy records, it was not always possible to distinguish involvement 
of paraortic and pelvic lymph nodes and they are considered together as ret- 
roperitoneal nodes. There were no obvious differences in the patterns of spread 
among the three subclasses of uterine sarcoma. There were no differences noted 
between the homologous and heterologous mixed mesodermal tumors. 
The histologic nature of the metastases were analyzed in those patients who 
had mixed mesodermal sarcoma. In four patients the metastases were found to 
be sarcoma only, two patients had metastases of carcinoma only, and in five 
patients the metastases were found to be both carcinoma and sarcoma. 
The direct causes of death are summarized in Table 2. Obstructive renal failure 
and respiratory failure due to tumor replacement or pneumonia were the most 
common direct causes of death. The interval between diagnosis and death averaged 
9 months (range 1 day to 47 months). More than 75% of the patients died within 
1 year of discovery of their sarcoma. 
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TABLE 1 
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10 6 21 
I 6 15 
I 4 13 
2 1 4 
2 0 2 
11 6 21 
8 6 16 
6 2 9 
3 1 4 
2 0 3 
1 1 3 
2 0 2 
0 1 1 
7 2 10 
1 0 2 
0 0 1 
1 0 1 




Uterine sarcomas constitute less than 5% of all uterine cancers and are char- 
acterized by an extremely poor survival rate for those patients who have extrauterine 
disease. Because of their rarity and the confusing array of classification schemes, 
no consensus exists as to their mode of spread or response to adjuvant therapy. 
Our study was undertaken to help elucidate the patterns of spread of uterine 
sarcoma in treatment failures and to determine if the various histologic subgroups 
have an affinity for spread to certain sites. 
TABLE 2 
DIRECT CAUSE OF DEATH 
Obstructive renal failure I 
Respiratory failure 7 
Pulmonary embolus 2 
Bowel perforation 2 
Not specified 4 
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Table 3 summarizes a review of previously reported autopsy findings. Because 
of confusing classification systems used in the past, it was not possible to decipher 
some of the older reports and this review is limited to reports with sufficient 
detail to classify. It was particularly difficult to obtain autopsy cases of pure 
endometrial stromal sarcoma since many of the older reports did not distinguish 
this tumor from endolymphatic stromal myosis. 
The previous findings parallel our own and there were no apparent differences 
in the patterns of tumor spread among the subgroups studied. Nodal involvement 
has been frequently reported with mixed mesodermal sarcoma and endometrial 
stromal sarcoma as was seen in our series (65% nodal involvement). However, 
nodal involvement with leiomyosarcoma has been an issue of controversy, but 
was seen in 2 of 5 patients in our series and in 13 of 29 previously reported 
autopsies, an overall incidence of 44%. Leiomyosarcomas are rarely diagnosed 
preoperatively, consequently nodal palpation and sampling is less likely to be 
done intraoperatively. This may explain the low frequency with which nodal 
disease has been discussed in clinical papers. 
Local control was infrequent with all tumor types. Disease occurrence outside 
the pelvis was found in 21 of 22 (95%) of our patients and in 56 of 58 (97%) of 
patients with previously reported autopsies. Overall 45% of the patients had 
disease limited to the abdomen and pelvis while 55% had disease above the 
diaphragm. It is readily apparent that widespread and distant metastases occur 
early in the course of the disease process and account for the vast majority of 
treatment failures, and that leiomyosarcoma, mixed mesodermal, and endometrial 
stromal sarcoma spread by direct extension, lymphatic, and hematogenous routes. 
It appears that intraperitoneal spread, in a fashion similar to carcinoma of the 
ovary, is also very common with these neoplasms. 
In summary, our findings reinforce the need for meticulous surgical staging 
which should include peritoneal washings, sampling of regional and paraortic 
lymph nodes, and biopsies of the omentum, diaphragm, liver, and peritoneum. 
Isolated pelvic failure is rare and effective systemic chemotherapy offers the 
most logical approach to improving survival. Adjuvant radiation therapy probably 
has a role in control of local disease but is unlikely to influence overall survival. 
TABLE 3 























Note. Compiled from Refs. [2, 5-141. 
L? One patient had a distant metastases only. 
172 FLEMING ET AL. 
REFERENCES 
1. Ober, W. B. Uterine sarcomas: Histogenesis and taxonomy, Ann. N.Y. Acad. Sci. 75,568 (1959). 
2. Norris, H. J., and Taylor, H. B. Mesenchymal tumors of the uterus. A clinical and pathological 
study of 53 endometrial stromal tumors, Cnncer 19, 755 (1966). 
3. Kempson, R. L., and Bari, W. Uterine sarcomas. Classification, diagnosis, and prognosis, Hum. 
Pathol. 1, 331 (1970). 
4. Yoonesi, M., and Hart, W. R. Endometrial stromal sarcoma, Cancer 40, 898 (1977). 
5. Kardash, T. Sarcoma of the uterus. Report of two cases with generalized metastases, Amer. J. 
Obstet. Gynecol. 56, 566 (1948). 
6. Davis, G. H., Howe, J. S., and French, W. G. Leiomyosarcoma of the uterus. Report of 16 
cases, 1917 to 1948, Amer. J. Obstet. Gynecol. 56, 1048 (1948). 
7. Wilson, L. A., Graham, L., Thornton, W. N., and Nokes, J. N. Mixed mesodermal tumors of 
the uterus, Amer. J. Obstet. Gynecol. 66, 718 (1953). 
8. Stemberg, W. H., Clark, W. H., and Smith, R. C. Malignant mixed mullerian tumor (mixed 
mesodermal tumor of the uterus). A study of 21 cases, Cancer 7, 704 (1954). 
9. Rubin, A. The histogenesis of carcinosarcoma (mixed mesodermal tumor) of the uterus as 
revealed by tissue culture studies, Amer. .I. Obstet. Gynecol. 77, 269 (1959). 
10. Futoran, J. M., and Jesurun, H. M. Endometrial stromal sarcoma, Amer. J. Obstet. Gynecol. 
84, 1830 (1962). 
11. Spiro, R. H., and Koss, L. G. Myosarcoma of the uterus, a clinicophathologic study, Cancer 
18, 571 (1965). 
12. Taylor, H. B., and Norris, H. J. Mesenchymal tumors of the uterus. IV. Diagnosis and prognosis 
of leiomyosarcoma, Arch. Pathol. 82, 40 (1966). 
13. Bartsch, E. G., O’Leary, J. A., and Moore, J. G. Carcinosarcoma of the uterus, Obstet. Gynecol. 
30, 518 (1967). 
14. Lotocki, R., Rosenshein, N. B., Grumbine, F., Dillon, M., Parmely, T., and Woodruff, J. D. 
Mixed mullerian tumors of the uterus: Clinical and pathologic correlations, Znt. J. Gynecol. 
Obstet. 20, 237 (1982). 
